New blood-based risk score refines heart disease risk classification for better prevention strategies.
- Scientists have developed a blood-based risk score based on lipids to improve risk prediction for individuals in the intermediate risk group for heart attacks or strokes.
- Traditional risk scores like the Framingham Risk Score have limitations in accurately assessing the intermediate-risk group.
- The lipidomic risk score aims to refine intermediate risk assessment and help clinicians target precise prevention and management strategies.
- The tool may streamline the selection of at-risk individuals for non-invasive imaging to enhance heart prevention and management.
- The goal is to prevent heart disease through better risk prediction, efficient use of health resources, and improved outcomes for individuals at high risk.
Source link
Cardiology, Public Health & Prevention, Internal Medicine